Keyphrases
Mucosal Immunity
100%
Bacteriophage
100%
Adjuvant-free
100%
Needle-free
100%
COVID-19 Vaccine
100%
Mucosal Vaccine
75%
Sterilizing Immunity
50%
Complete Protection
50%
Bronchoalveolar Lavage
50%
COVID-19
50%
Two-dose
50%
Bacteriophage T4
50%
SARS-CoV-2 Variants
50%
SARS-CoV-2 Vaccine
50%
Humoral Immune Response
25%
Cellular Immune Response
25%
United States
25%
Knock-in Mouse Model
25%
T Cell Immunity
25%
Secretory Immunoglobulin A (SIgA)
25%
Virus-neutralizing Antibody
25%
Non-infectious
25%
Viral Transmission
25%
Transgenic Mouse Model
25%
Angiotensin-converting Enzyme 2 (ACE2)
25%
Cell-mediated Immune Response
25%
Vaccine Response
25%
Delivery Platform
25%
Respiratory Infection
25%
Cytokine Response
25%
Antibody Titer
25%
Titer
25%
Gut Microbiota
25%
World Health Organization
25%
Intranasal Vaccine
25%
Ambient Temperature
25%
Intramuscularly
25%
Capsid
25%
Nucleocapsid Protein
25%
Virus Neutralization
25%
Lung Lesions
25%
Intranasal Administration
25%
Emergency Preparedness
25%
Angiotensin-converting Enzyme
25%
Neutralization Antibody
25%
Phage T4
25%
Nasal Vaccination
25%
Spike Trimer
25%
Mucosal Vaccine Delivery
25%
Delta Variant
25%
Multiple Variants
25%
Omicron Variant
25%
CD81 T Cells
25%
CD41 T Cells
25%
Pandemic Pathogens
25%
COVID Vaccine
25%
Mouse-adapted SARS-CoV-2
25%
Emerging Epidemics
25%
Medicine and Dentistry
Mucosal Immunity
100%
Mucosal Vaccine
100%
COVID-19 Vaccine
100%
Bacteriophage
100%
Cellular Immunity
75%
Severe Acute Respiratory Syndrome Coronavirus 2
75%
Enterobacteria Phage T4
75%
COVID-19
50%
Lung Lavage
50%
Neutralizing Antibody
50%
Infection
25%
Virus Capsid
25%
Virus Transmission
25%
Humoral Immunity
25%
Secretory Immunoglobulin
25%
Health Care Cost
25%
Pathogen
25%
Transgenic Mouse
25%
Immunity
25%
Respiratory Tract Infection
25%
Cytokine Response
25%
Lung Lesion
25%
Gut Microbiota
25%
Nucleocapsid Protein
25%
Intranasal Drug Administration
25%
Dipeptidyl Carboxypeptidase
25%
Omicron Coronavirus Variant
25%
Nasal Vaccine
25%
Immunology and Microbiology
Bacteriophage
100%
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Mucosal Immunity
80%
Adoptive Immunity
60%
Enterobacteria Phage T4
60%
Neutralizing Antibody
40%
Humoral Immunity
20%
Virus Transmission
20%
Capsid
20%
Infectious Agent
20%
Mouse Model
20%
Titer
20%
Intestine Flora
20%
Antibody Titer
20%
Transgenic Mouse
20%
CD81
20%
Virus Nucleocapsid
20%
Immunity
20%
Cytokine Response
20%
Spike
20%
Secretory Immunoglobulin
20%
Environmental Temperature
20%
Omicron Coronavirus Variant
20%